CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Up 152.1% in January

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totaling 2,816 shares, an increase of 152.1% from the December 31st total of 1,117 shares. Based on an average daily trading volume, of 13,587 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily trading volume, of 13,587 shares, the days-to-cover ratio is presently 0.2 days.

CSPC Pharmaceutical Group Stock Up 3.3%

OTCMKTS CSPCY traded up C$0.17 during mid-day trading on Thursday, reaching C$5.25. 978 shares of the stock were exchanged, compared to its average volume of 4,816. CSPC Pharmaceutical Group has a 1-year low of C$2.20 and a 1-year high of C$5.83. The business’s fifty day simple moving average is C$4.35 and its 200 day simple moving average is C$4.62.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.